Search results for: 'research area cell cycle rad51'
-
B1307 SJB3-019ATarget: USPSummary: Usp1 inhibitor
-
B2298 Plinabulin (NPI-2358)Target: Vascular Disrupting Agents (VDA)Summary: vascular disrupting agent
-
B3425 Y-320Summary: immunomodulator
-
C3095 N-OxalylglycineSummary: cell permeable inhibitor of α-ketoglutarate-dependent enzymes, including JMJD2A, JMJD2C, and JMJD2E.
-
B5211 MLCK inhibitor peptide 18Summary: A cell-permeable inhibitor with high selectivity for myosin light chain kinase (MLCK)
-
A3847 SU5416Target: VEGFRSummary: VEGF receptor inhibitor and AHR agonist
-
B1154 Oxonic acid potassium saltSummary: Uricase inhibitor
-
A4407 FumagillinSummary: Antibiotic and antiangiogenic agent
-
A3268 CAL-130 HydrochlorideSummary: PI3K inhibitor
-
A3628 MLN120BSummary: IκB Kinase β Inhibitor